Illumina Inc

ILMN

Equity

ISIN US4523271090 / Valor 1111080

NASDAQ (2024-09-18)

USD 130.97+0.58%

Illumina Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Illumina Inc is a global company that specializes in applying innovative technologies to the analysis of genetic variation and function. The company focuses on delivering flexible and scalable solutions to meet the needs of its customers in the fields of life science research, translational and consumer genomics, and molecular diagnostics. Illumina's innovative sequencing and array technologies have been instrumental in fueling groundbreaking advancements in these areas, allowing for studies that were previously unimaginable. The company values collaborative interactions, rapid delivery of solutions, and providing the highest level of quality in its products and services.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Decline

Illumina Inc's revenue for the first quarter of fiscal year 2024 was $1.08 billion, representing a 1% decrease from the $1.09 billion reported in the first quarter of 2023. This decline was consistent on a constant currency basis.

Operating Margins

For Q1 2024, Illumina Inc reported a GAAP operating margin of 11.0% and a non-GAAP operating margin of 20.6%. These figures reflect the company's focus on operational excellence and cost-saving measures.

Earnings Per Share

Illumina Inc's GAAP diluted loss per share for the first quarter of 2024 was ($0.79), a significant drop compared to the GAAP diluted earnings per share of $0.02 in Q1 2023. However, the non-GAAP diluted earnings per share improved to $0.09 from $0.08 in the same period last year.

Cash Flow and Investments

In Q1 2024, Illumina Inc generated $77 million in cash flow from operations, a substantial increase from the $10 million reported in Q1 2023. The company also reported free cash flow of $41 million for the quarter, compared to a negative free cash flow of $(42) million in the prior year period.

Financial Outlook

Illumina Inc reiterated its fiscal year 2024 guidance, expecting Core Illumina revenue to remain approximately flat compared to 2023. The company also anticipates a Core Illumina non-GAAP operating margin of around 20% for the fiscal year.

Summarized from source with an LLMView Source

Key figures

-8.03%1Y

-70.7%3Y

-56.8%5Y

Performance

42.5%1Y

46.6%3Y

44.3%5Y

Volatility